Position in GILD
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,076,344,612
-$9,451,844 QoQ
Shares Held
7,722,929
-12.7% QoQ
Ownership
0.622%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 81.26336523357912.ToString("F0")%
Shared 10.749690952746036.ToString("F0")%
None 7.986943813674838.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. GILD ranks #8 (6.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,832,514 | $3,870,099,719 | |
| 2 | LLY |
ELI LILLY & Co
|
3,895,925 | $3,583,354,934 | |
| 3 | MRK |
Merck & Co., Inc.
|
15,456,039 | $1,859,206,929 | |
| 4 | ABBV |
AbbVie Inc.
|
7,411,238 | $1,611,870,150 | |
| 5 | NVS |
Novartis AG
|
8,110,116 | $1,238,820,217 | |
| 6 | AMGN |
Amgen Inc
|
3,304,344 | $1,162,633,435 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,762,589 | $1,137,951,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
7,722,929 | $1,076,344,612 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,076,344,612 | 7,722,929 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,085,796,456 | 8,846,313 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,060,912,248 | 9,557,768 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,122,507,414 | 10,124,537 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,176,576,206 | 10,500,457 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,072,194,194 | 11,607,602 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $978,360,398 | 11,669,375 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $714,395,654 | 10,412,413 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $743,063,014 | 10,144,205 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $792,536,625 | 9,783,195 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $711,638,857 | 9,496,115 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $699,929,469 | 9,081,737 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $748,330,737 | 9,019,293 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $770,308,781 | 8,972,729 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $560,690,660 | 9,088,842 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $544,458,699 | 8,808,586 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $506,615,124 | 8,521,701 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $529,324,503 | 7,289,967 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $471,392,364 | 6,748,638 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $403,125,032 | 5,854,270 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $285,567,331 | 4,418,495 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $296,516,250 | 5,089,534 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $322,236,646 | 5,099,488 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $404,338,935 | 5,255,250 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $387,723,377 | 5,186,241 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||